Heterologous antisera specific for murine T-cell antigen-recognition molecules were prepared by immunization of rabbits with dinitrophenyl-specific murine T-cell suppressor factors that had been purified by hapten-affinity chromatography. The antisera (i) bind to antigen-specific T-cell products that differ in their antigen-recognizing specificity; (ii) absorb the specific suppressor activity in preparations containing suppressor factors; (iii) stain all Lyt2+ T cells brightly in indirect immunofluorescence examination, stain some Lyt1+ cells (with low intensity), and do not stain B cells; (iv) precipitate cell membrane proteins from T cells that bear striking structural resemblance to the antigen-specific molecules used for immunization. These results suggest that, like B cells, there is a commonality between antigen-specific effector molecules released by T cells and their membrane-associated receptors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC349049PMC
http://dx.doi.org/10.1073/pnas.78.10.6411DOI Listing

Publication Analysis

Top Keywords

heterologous antisera
8
antigen-specific t-cell
8
t-cell products
8
murine t-cell
8
suppressor factors
8
cells
6
characterization t-cell
4
t-cell surface
4
surface proteins
4
proteins bound
4

Similar Publications

Background: The heterologous three-dose schedule of the protein subunit anti-COVID-19 SOBERANA®02 and SOBERANA® Plus vaccines has proved its safety, immunogenicity and efficacy in pediatric population, but durability of immunogenicity is not yet dilucidated. This study reports the safety and durability of the humoral and cellular responses in children and adolescents 5-7 months after receiving the heterologous vaccine schedule of SOBERANA® 02 and SOBERANA® Plus.

Methods: Children participating in a phase I/II clinical trial were followed-up for 5-7 months after the last dose.

View Article and Find Full Text PDF

The spread of multidrug-resistant strains of poses a great challenge in gonorrhea treatment. At present, vaccination is the best strategy for gonorrhea control. However, given the extensive antigenic variability of , the effectiveness of monovalent vaccines is limited.

View Article and Find Full Text PDF

Diseases caused by Streptococcus pneumoniae (pneumococcus) produce a great impact on public health, killing about one million people annually despite available vaccines. Recent research has revealed that the pneumococcus produces extracellular vesicles (pEVs), which display selective cargo and hold potential for vaccine development. Here, we evaluated the immunogenicity and protective potential of pEVs derived from a non-encapsulated pneumococcal strain (R6) using murine models of pneumococcal colonization and invasive pneumonia.

View Article and Find Full Text PDF

The Hepatitis B core antigen (HBcAg) has been used as a carrier of several heterologous protein fragments based on its capacity to form virus-like particles (VLPs) and to activate innate and adaptive immune responses. In the present work, two chimeric proteins were designed as potential pancorona vaccine candidates, comprising the N- or C- terminal domain of SARS-CoV-2 nucleocapsid (N) protein fused to HBcAg. The recombinant proteins, obtained in E.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of antibodies from Japanese encephalitis virus (JEV) and Zika virus (ZIKV) infections on each other, focusing on a phenomenon called antibody-dependent enhancement (ADE), where the presence of one virus's antibodies can worsen the infection by the other virus.* -
  • Researchers created modified vaccine candidates using recombinant adenoviruses and mRNA to examine their effectiveness in generating immune responses against JEV and the potential for cross-reactivity with ZIKV, finding that certain modifications lead to a reduced risk of ADE.* -
  • Immunization with the modified vaccine candidates resulted in lower cross-reactive antibody levels and effective T cell responses, indicating that these vaccines could protect against JEV while minimizing the dangers
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!